FDA ACCEPTS NEW DRUG APPLICATION FOR SEYSARA™ (SARECYCLINE) FOR THE TREATMENT OF MODERATE-TO-SEVERE ACNE.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2018, v. 11, n. 10, p. 46
- Publication type:
- Article
Works matching DE "PARATEK Pharmaceuticals Inc."
Results: 2
1
2
Deal watch: Novartis acquires marketing rights for novel broad-spectrum antibiotic.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3064
- Publication type:
- Article